U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549451) titled 'Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms' on April 20.
Brief Summary: To learn if imetelstat can help to control MDS/MPNs.
Study Start Date: Oct. 08, 2026
Study Type: INTERVENTIONAL
Condition:
Phase II
Imetelstat
Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases
Intervention:
DRUG: Imetelstat
Given by IV
Recruitment Status: NOT_YET_RECRUITING
Sponsor: M.D. Anderson Cancer Center
Disclaimer: Curated by HT Syndication....